Paliperidona Alter (Paliperidone)

Paliperidone, the active ingredient in Paliperidona Alter, is an atypical antipsychotic presented as a oral tablet for oral use. It treats schizophrenia, schizoaffective disorder, and acute exacerbations of schizophrenia in adult patients. GNH USA supplies Paliperidona Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidona Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paliperidone is an atypical antipsychotic that modulates dopaminergic and serotonergic pathways in psychotic disorders.

- Schizophrenia: Reduces positive and negative symptoms and helps maintain stability. - Schizoaffective disorder: Improves mood and psychotic symptom control. - Acute exacerbation of schizophrenia: Provides rapid symptom relief during flare‑ups.

Paliperidone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Akathisia: Restlessness and an urge to move. - Weight gain: Increased appetite leading to modest weight increase. - Somnolence: Drowsiness or fatigue. - Constipation: Reduced bowel motility. - Dry mouth: Decreased salivation. - Hyperprolactinemia: Elevated prolactin levels causing menstrual changes.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: Potentially life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: Involuntary, repetitive movements. - Seizures: Increased risk of convulsive episodes. - Orthostatic hypotension: Drop in blood pressure upon standing. - Cardiac arrhythmias: Irregular heart rhythms. - Elevated QT‑c interval :  

Paliperidone requires careful ​​  

-        ewline ");